Hangzhou Tigermed Consulting (300347) — Cash Flow Reinvestment Rate
Hangzhou Tigermed Consulting (300347) has a Cash Flow Reinvestment Rate of 0.15x as of September 2025, reinvesting CN¥72.75 Million (capex CN¥72.75 Million ) from operating cash flow of CN¥475.40 Million. Explore Hangzhou Tigermed Consulting capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Tigermed Consulting Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Hangzhou Tigermed Consulting across 17 annual periods. Also explore Hangzhou Tigermed Consulting asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hangzhou Tigermed Consulting (2009–2025)
Year-by-year capital reinvestment analysis for Hangzhou Tigermed Consulting. For live market cap and broader valuation context, see Hangzhou Tigermed Consulting (300347) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | CN¥1.13 Billion | CN¥1.12 Billion | CN¥214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | CN¥4.38 Billion | CN¥1.10 Billion | CN¥356.55 Million | ▲ +148.6% |
| 2023 | 1.61x | CN¥1.85 Billion | CN¥1.15 Billion | CN¥313.76 Million | ▼ -2.1% |
| 2022 | 1.64x | CN¥2.23 Billion | CN¥1.36 Billion | CN¥448.60 Million | ▼ -6.8% |
| 2021 | 1.76x | CN¥2.51 Billion | CN¥1.42 Billion | CN¥368.62 Million | ▼ -13.1% |
| 2020 | 2.03x | CN¥2.02 Billion | CN¥998.68 Million | CN¥156.50 Million | ▲ +73.7% |
| 2019 | 1.17x | CN¥615.55 Million | CN¥527.56 Million | CN¥102.91 Million | ▲ +74.7% |
| 2018 | 0.67x | CN¥348.83 Million | CN¥522.24 Million | CN¥91.72 Million | ▼ -46.4% |
| 2017 | 1.25x | CN¥392.46 Million | CN¥314.97 Million | CN¥45.96 Million | ▼ -59.6% |
| 2016 | 3.08x | CN¥591.66 Million | CN¥191.91 Million | CN¥61.66 Million | ▲ +121.6% |
| 2015 | 1.39x | CN¥258.36 Million | CN¥185.73 Million | CN¥87.08 Million | ▲ +59.4% |
| 2014 | 0.87x | CN¥38.10 Million | CN¥43.66 Million | CN¥38.10 Million | ▲ +79.7% |
| 2013 | 0.49x | CN¥37.45 Million | CN¥77.10 Million | CN¥37.45 Million | ▼ -66.5% |
| 2012 | 1.45x | CN¥21.69 Million | CN¥14.98 Million | CN¥21.69 Million | ▲ +244.9% |
| 2011 | 0.42x | CN¥16.24 Million | CN¥38.69 Million | CN¥16.24 Million | ▲ +34.6% |
| 2010 | 0.31x | CN¥8.29 Million | CN¥26.59 Million | CN¥8.29 Million | ▼ -50.7% |
| 2009 | 0.63x | CN¥13.88 Million | CN¥21.95 Million | CN¥13.88 Million | — |